Fundraising FoxPolyActiva
1 known investors
Find your way into PolyActiva
Sign up to see every warm intro you have to PolyActiva
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PolyActiva team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PolyActiva develops biodegradable ophthalmic drug-delivery therapies for blinding eye diseases, including rare pediatric retinal conditions with no approved treatments. It uses its PREZIA platform to create new chemical entity-eligible pro-drug candidates.
Investors · 1
Frequently asked questions
- What does PolyActiva do?
- PolyActiva develops biodegradable ophthalmic drug-delivery therapies for blinding eye diseases, including rare pediatric retinal conditions with no approved treatments. It uses its PREZIA platform to create new chemical entity-eligible pro-drug candidates.
- Who are PolyActiva's investors?
- PolyActiva's investors include Yuuwa Capital.